Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy

Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in MTC. To date, however, there are no published rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossrubatscher, Erika, Fanciulli, Giuseppe, Pes, Luca, Sesti, Franz, Dolci, Carlotta, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693147/
https://www.ncbi.nlm.nih.gov/pubmed/33138305
http://dx.doi.org/10.3390/jcm9113507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693147/
https://www.ncbi.nlm.nih.gov/pubmed/33138305
http://dx.doi.org/10.3390/jcm9113507

Ejemplares similares